Doripenem in the Treatment of Complicated Intra-Abdominal Infections

NCT00210938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections and Mycoses
Appendicitis
Cholecystitis
Pancreatitis
Peritonitis

Interventions

DRUG: Doripenem

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]